10x Genomics, Inc.
Expected move
InputsNext report
Last report
Largest filed tie
13F top-10 QoQ
Top fund weight
Last report0 of 8 at or beyond impliedshaded = implied▲▼ = realized× = |realized| ÷ implied
+14.10%
vs ±14.8% implied · ×0.96
shaded = implied · ▲▼ = realized
No thesis.
10x Genomics, Inc.
70.25
Fund move
Fund move
| Rank | Manager | Value | % 13F | ||
|---|---|---|---|---|---|
| 1 | FMRFMR | $675.9M | 13.66% | −0.63% | |
| 2 | BlackRockBlackRockindex-like | $414.2M | 8.37% | +7.18% | |
| 3 | ARK Investment ManagementARK | $383.5M | 7.75% | −14.63% | |
| 4 | Vanguard Portfolio ManagementVanguard Portfolioindex-like | $267.7M | 5.41% | +1.01% | |
| 5 | Quantinno Capital ManagementQuantinno | $209.7M | 4.24% | +1.07% | |
| 6 | Vanguard Capital ManagementVanguardindex-like | $194.9M | 3.94% | −3.55% | |
| 7 | T. Rowe Price AssociatesT. Rowe Price | $174.0M | 3.52% | +2681.00% | |
| 8 | Sumitomo Mitsui Trust HoldingsSumitomo Mitsui Trust | $160.8M | 3.25% | −17.92% | |
| 9 | Nikko Asset Management AmericasNikko Asset Management Americas | $160.7M | 3.25% | −17.86% | |
| 10 | Morgan StanleyMorgan Stanley | $128.5M | 2.60% | +26.18% | |
| 11 | Goldman Sachs GroupGoldman Sachs | $120.7M | 2.44% | −23.37% | |
| 12 | Geode Capital ManagementGeodeindex-like | $118.2M | 2.39% | +6.15% | |
| 13 | Citadel AdvisorsCitadel | $113.7M | 2.30% | +218.36% | |
| 14 | State StreetState Streetindex-like | $107.4M | 2.17% | +8.21% | |
| 15 | Dimensional Fund AdvisorsDimensional | $85.3M | 1.72% | +8.93% | |
| 16 | Jacobs Levy Equity ManagementJacobs Levy Equity | $77.4M | 1.57% | −11.54% | |
| 17 | AQR Capital ManagementAQR | $74.7M | 1.51% | −20.16% | |
| 18 | Point72 Asset ManagementPoint72 | $71.0M | 1.44% | new | |
| 19 | Capital World InvestorsCapital World Investors | $57.2M | 1.16% | +2.80% | |
| 20 | T. Rowe Price Investment ManagementT. Rowe Price | $48.6M | 0.98% | −0.97% | |
| 21 | Northern TrustNorthern Trustindex-like | $43.9M | 0.89% | +9.16% | |
| 22 | NuveenNuveenindex-like | $43.1M | 0.87% | +79.71% | |
| 23 | Charles Schwab Investment ManagementCharles Schwabindex-like | $41.7M | 0.84% | −3.54% | |
| 24 | Casdin CapitalCasdin Capital | $40.3M | 0.81% | −53.85% | |
| 25 | Connor, Clark & Lunn Investment ManagementConnor, Clark & Lunn | $37.9M | 0.77% | +5.32% |
391 managers report $4.9B of 10x Genomics on form 13F for the quarter ended Jun 30 '26. 29 of them hold 80% of it; FMR is largest at 13.66%.
Linked news
Expected move
Inputs8Q avg ±6.0%·×2.66·rich
straddle ±19.2%
spot 70.11exp Nov 20ATM strike 70ATM straddle 15.80IV 118%